SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
MGI PHARMA, INC. and Helsinn Healthcare SA Announce Submission of Supplemental New Drug Application for Aloxi(R) Injection in Post-Operative Nausea and Vomiting